These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 2908062)

  • 1. Naloxone, but not Tyr-MIF-1, reduces volitional ethanol drinking in rats: correlation with degree of spontaneous preference.
    Pulvirenti L; Kastin AJ
    Pharmacol Biochem Behav; 1988 Sep; 31(1):129-34. PubMed ID: 2908062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential effects of Tyr-MIF-1, MIF-1, and naloxone on peptide YY-induced hyperphagia.
    Hagan MM; Moss DE
    Peptides; 1994; 15(2):243-5. PubMed ID: 7911993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential effects of Tyr-MIF-1 and naloxone in two animal models involving benzodiazepine.
    Kastin AJ; Schwartzenburg D; Tsui L; Miller LG; Olson GA; Olson RD
    Brain Res Bull; 1989 Dec; 23(6):443-6. PubMed ID: 2575442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tyr-MIF-1 acts as an opiate antagonist in the tail-flick test.
    Kastin AJ; Stephens E; Ehrensing RH; Fischman AJ
    Pharmacol Biochem Behav; 1984 Dec; 21(6):937-41. PubMed ID: 6151669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tyr-MIF-1 attenuates antinociceptive responses induced by three models of stress-analgesia.
    Galina ZH; Kastin AJ
    Br J Pharmacol; 1987 Apr; 90(4):669-74. PubMed ID: 2884005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cimetidine does not change the effect of Tyr-MIF-1 (Tyr-Pro-Leu-Gly-NH2) on the opiate form of footshock-induced analgesia.
    Krowicki ZK
    Life Sci; 1991; 49(16):1163-8. PubMed ID: 1680211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Tyr-W-MIF-1 analog containing D-Pro2 discriminates among antinociception in mice mediated by different classes of mu-opioid receptors.
    Nakayama D; Watanabe C; Watanabe H; Mizoguchi H; Sakurada T; Sakurada S
    Eur J Pharmacol; 2007 Jun; 563(1-3):109-16. PubMed ID: 17343845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intrathecal Tyr-W-MIF-1 produces potent, naloxone-reversible analgesia modulated by alpha 2-adrenoceptors.
    Gergen KA; Zadina JE; Kastin AJ; Paul D
    Eur J Pharmacol; 1996 Mar; 298(3):235-9. PubMed ID: 8846821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopamine receptor antagonists block the effect of Tyr-MIF-1 (Tyr-Pro-Leu-Gly-NH2) on the opiate form of footshock-induced analgesia.
    Krowicki ZK
    Neuropeptides; 1991 Aug; 19(4):281-5. PubMed ID: 1681456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tyr-MIF-1 and hemorphin can act as opiate agonists as well as antagonists in the guinea pig ileum.
    Zadina JE; Kastin AJ; Kersh D; Wyatt A
    Life Sci; 1992; 51(11):869-85. PubMed ID: 1355851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Free-choice responding for ethanol versus water in alcohol preferring (P) and unselected Wistar rats is differentially modified by naloxone, bromocriptine, and methysergide.
    Weiss F; Mitchiner M; Bloom FE; Koob GF
    Psychopharmacology (Berl); 1990; 101(2):178-86. PubMed ID: 2349359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sex differences in naloxone- and Tyr-MIF-1-induced hypoalgesia.
    Kavaliers M; Innes DG
    Peptides; 1993; 14(5):1001-4. PubMed ID: 7904339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brain peptide reverses effect of morphine on human lymphocytes.
    Strimas JH; Chi DS; Kastin AJ
    Peptides; 1987; 8(6):1165-7. PubMed ID: 2894648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tyr-W-MIF-1-induced conditioned place preference.
    Nores WL; Olson RD; Olson GA; Vaccarino AL; Bell RL; Zadina JE; Kastin AJ
    Peptides; 1999; 20(4):479-84. PubMed ID: 10458518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MIF-1 and Tyr-MIF-1 fail to alter benzodiazepine-induced hypothermia.
    Kastin AJ; Miller LG; Schwartzenburg DS
    Pharmacol Biochem Behav; 1989 May; 33(1):261-3. PubMed ID: 2571169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prolonged analgesia after intracerebroventricular Tyr-W-MIF-1 (Tyr-Pro-Trp-Gly-NH2).
    Zadina JE; Kastin AJ; Kenigs V; Bruno C; Hackler L
    Neurosci Lett; 1993 Jun; 155(2):220-2. PubMed ID: 8104325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute administration of MIF-1 or Tyr-MIF-1 inhibits haloperidol-induced catalepsy in rats.
    Hara C; Kastin AJ
    Pharmacol Biochem Behav; 1986 Jun; 24(6):1785-7. PubMed ID: 2874569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential inhibitory effects of MIF-1, Tyr-MIF-1, naloxone and beta-funaltrexamine on body rotation-induced analgesia in the meadow vole, Microtus pennsylvanicus.
    Lipa SM; Kavaliers M; Ossenkopp KP
    Peptides; 1989; 10(3):493-7. PubMed ID: 2571138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MIF-I's differential actions as an opiate antagonist.
    Kastin AJ; Olson RD; Ehrensing RH; Berzas MC; Schally AV; Coy DH
    Pharmacol Biochem Behav; 1979 Dec; 11(6):721-3. PubMed ID: 43981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Tyr-W-MIF-1 analog containing D-Pro2 acts as a selective mu2-opioid receptor antagonist in the mouse.
    Watanabe H; Nakayama D; Ito K; Watanabe C; Mizoguchi H; Fujimura T; Murayama K; Kawamura S; Sato T; Sakurada C; Sakurada T; Sakurada S
    J Pharmacol Exp Ther; 2005 Mar; 312(3):1075-81. PubMed ID: 15561796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.